F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Ribavirin

Page 1 of 2 ( 51 items )
<<
1
2
>>

1	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 337 \| Download: 956
2	Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages 6/24/2021 7:26:32 AM \| Browse: 477 \| Download: 1109
3	Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over 9/21/2020 4:02:08 PM \| Browse: 676 \| Download: 1529
4	Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature 5/6/2019 10:43:10 AM \| Browse: 996 \| Download: 1633
5	Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus 4/4/2018 1:15:45 PM \| Browse: 1200 \| Download: 1903
6	Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 12/5/2017 1:55:00 AM \| Browse: 1074 \| Download: 1890
7	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1408 \| Download: 2105
8	Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection 2/6/2017 9:08:00 AM \| Browse: 1054 \| Download: 2199
9	Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin 1/22/2017 8:28:00 AM \| Browse: 1336 \| Download: 2181
10	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1091 \| Download: 2297
11	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1531 \| Download: 2375
12	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 10/12/2016 2:18:00 PM \| Browse: 1217 \| Download: 1415
13	Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience 8/3/2016 8:11:00 AM \| Browse: 1534 \| Download: 2383
14	Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus 3/2/2016 1:35:00 PM \| Browse: 1782 \| Download: 2938
15	Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma 2/25/2016 7:04:00 PM \| Browse: 1187 \| Download: 2082
16	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1176 \| Download: 2335
17	Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy 1/23/2016 5:08:00 PM \| Browse: 1470 \| Download: 1893
18	Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C 1/20/2016 5:04:00 PM \| Browse: 1115 \| Download: 1767
19	Ribavirin: Past, present and future 1/15/2016 9:49:00 AM \| Browse: 1396 \| Download: 1657
20	Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management 1/15/2016 9:49:00 AM \| Browse: 1211 \| Download: 1429
21	Hepatitis C genotype 4: The past, present, and future 12/4/2015 3:24:00 PM \| Browse: 1392 \| Download: 2374
22	Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients 12/2/2015 12:20:00 PM \| Browse: 1665 \| Download: 1832
23	Hepatitis C in hemodialysis patients 12/2/2015 12:01:00 PM \| Browse: 1164 \| Download: 1474
24	Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development 11/27/2015 5:17:00 PM \| Browse: 1401 \| Download: 2306
25	Hepatitis E virus infection: Epidemiology and treatment implications 11/12/2015 5:09:00 PM \| Browse: 1226 \| Download: 2123
26	Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance 11/9/2015 6:35:00 PM \| Browse: 1339 \| Download: 1615
27	Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 6/29/2015 4:40:00 PM \| Browse: 1308 \| Download: 2263
28	Hepatitis C: New challenges in liver transplantation 5/20/2015 5:01:00 PM \| Browse: 1131 \| Download: 2068
29	Natural interferon-beta treatment for patients with chronic hepatitis C in Japan 5/19/2015 5:28:00 PM \| Browse: 1257 \| Download: 1712
30	Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study 5/18/2015 5:02:00 PM \| Browse: 1319 \| Download: 1565
31	Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection 5/18/2015 5:02:00 PM \| Browse: 1007 \| Download: 1560
32	Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control 3/30/2015 5:46:00 PM \| Browse: 1318 \| Download: 2062
33	Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6 3/13/2015 3:29:00 PM \| Browse: 1300 \| Download: 1696
34	Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings 2/11/2015 5:56:00 PM \| Browse: 1438 \| Download: 1973
35	Retreatment with peginterferon and ribavirin in chronic hepatitis C 2/11/2015 5:56:00 PM \| Browse: 1123 \| Download: 1409
36	Study of pruritus in chronic hepatitis C patients 12/20/2014 9:24:00 PM \| Browse: 1205 \| Download: 1696
37	Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection 12/5/2014 11:43:00 AM \| Browse: 1246 \| Download: 1593
38	New treatments for chronic hepatitis C: an overview for paediatricians 12/5/2014 11:43:00 AM \| Browse: 1425 \| Download: 1964
39	Telaprevir/boceprevir era: From bench to bed and back 9/16/2014 8:07:00 PM \| Browse: 1497 \| Download: 1599
40	Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients 9/16/2014 4:56:00 PM \| Browse: 1156 \| Download: 848
41	Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C 9/16/2014 3:23:00 PM \| Browse: 1080 \| Download: 883
42	Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 9/15/2014 8:53:00 PM \| Browse: 1320 \| Download: 1225
43	Hepatitis C, stigma and cure 9/12/2014 8:41:00 PM \| Browse: 1408 \| Download: 1155
44	Hepatitis C genotype 6: A concise review and response-guided therapy proposal 9/10/2014 4:40:00 PM \| Browse: 1220 \| Download: 1161
45	Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy 9/5/2014 2:19:00 PM \| Browse: 1092 \| Download: 1143
46	Challenges in managing hepatitis C virus infection in cancer patients 9/1/2014 2:51:00 PM \| Browse: 1059 \| Download: 848
47	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection 9/1/2014 2:51:00 PM \| Browse: 1222 \| Download: 1229
48	Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children 8/28/2014 5:50:00 PM \| Browse: 1545 \| Download: 1224
49	Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C 8/26/2014 3:10:00 PM \| Browse: 1248 \| Download: 1490
50	Emerging therapeutic options for the management of hepatitis C infection 8/26/2014 2:46:00 PM \| Browse: 1122 \| Download: 1029

Page 1 of 2 ( 51 items )
<<
1
2
>>

1	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 337 \| Download: 956
2	Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages 6/24/2021 7:26:32 AM \| Browse: 477 \| Download: 1109
3	Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over 9/21/2020 4:02:08 PM \| Browse: 676 \| Download: 1529
4	Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature 5/6/2019 10:43:10 AM \| Browse: 996 \| Download: 1633
5	Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus 4/4/2018 1:15:45 PM \| Browse: 1200 \| Download: 1903
6	Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 12/5/2017 1:55:00 AM \| Browse: 1074 \| Download: 1890
7	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1408 \| Download: 2105
8	Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection 2/6/2017 9:08:00 AM \| Browse: 1054 \| Download: 2199
9	Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin 1/22/2017 8:28:00 AM \| Browse: 1336 \| Download: 2181
10	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1091 \| Download: 2297
11	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1531 \| Download: 2375
12	Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 10/12/2016 2:18:00 PM \| Browse: 1217 \| Download: 1415
13	Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience 8/3/2016 8:11:00 AM \| Browse: 1534 \| Download: 2383
14	Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus 3/2/2016 1:35:00 PM \| Browse: 1782 \| Download: 2938
15	Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma 2/25/2016 7:04:00 PM \| Browse: 1187 \| Download: 2082
16	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1176 \| Download: 2335
17	Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy 1/23/2016 5:08:00 PM \| Browse: 1470 \| Download: 1893
18	Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C 1/20/2016 5:04:00 PM \| Browse: 1115 \| Download: 1767
19	Ribavirin: Past, present and future 1/15/2016 9:49:00 AM \| Browse: 1396 \| Download: 1657
20	Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management 1/15/2016 9:49:00 AM \| Browse: 1211 \| Download: 1429
21	Hepatitis C genotype 4: The past, present, and future 12/4/2015 3:24:00 PM \| Browse: 1392 \| Download: 2374
22	Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients 12/2/2015 12:20:00 PM \| Browse: 1665 \| Download: 1832
23	Hepatitis C in hemodialysis patients 12/2/2015 12:01:00 PM \| Browse: 1164 \| Download: 1474
24	Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development 11/27/2015 5:17:00 PM \| Browse: 1401 \| Download: 2306
25	Hepatitis E virus infection: Epidemiology and treatment implications 11/12/2015 5:09:00 PM \| Browse: 1226 \| Download: 2123
26	Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance 11/9/2015 6:35:00 PM \| Browse: 1339 \| Download: 1615
27	Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 6/29/2015 4:40:00 PM \| Browse: 1308 \| Download: 2263
28	Hepatitis C: New challenges in liver transplantation 5/20/2015 5:01:00 PM \| Browse: 1131 \| Download: 2068
29	Natural interferon-beta treatment for patients with chronic hepatitis C in Japan 5/19/2015 5:28:00 PM \| Browse: 1257 \| Download: 1712
30	Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study 5/18/2015 5:02:00 PM \| Browse: 1319 \| Download: 1565
31	Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection 5/18/2015 5:02:00 PM \| Browse: 1007 \| Download: 1560
32	Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control 3/30/2015 5:46:00 PM \| Browse: 1318 \| Download: 2062
33	Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6 3/13/2015 3:29:00 PM \| Browse: 1300 \| Download: 1696
34	Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings 2/11/2015 5:56:00 PM \| Browse: 1438 \| Download: 1973
35	Retreatment with peginterferon and ribavirin in chronic hepatitis C 2/11/2015 5:56:00 PM \| Browse: 1123 \| Download: 1409
36	Study of pruritus in chronic hepatitis C patients 12/20/2014 9:24:00 PM \| Browse: 1205 \| Download: 1696
37	Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection 12/5/2014 11:43:00 AM \| Browse: 1246 \| Download: 1593
38	New treatments for chronic hepatitis C: an overview for paediatricians 12/5/2014 11:43:00 AM \| Browse: 1425 \| Download: 1964
39	Telaprevir/boceprevir era: From bench to bed and back 9/16/2014 8:07:00 PM \| Browse: 1497 \| Download: 1599
40	Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients 9/16/2014 4:56:00 PM \| Browse: 1156 \| Download: 848
41	Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C 9/16/2014 3:23:00 PM \| Browse: 1080 \| Download: 883
42	Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 9/15/2014 8:53:00 PM \| Browse: 1320 \| Download: 1225
43	Hepatitis C, stigma and cure 9/12/2014 8:41:00 PM \| Browse: 1408 \| Download: 1155
44	Hepatitis C genotype 6: A concise review and response-guided therapy proposal 9/10/2014 4:40:00 PM \| Browse: 1220 \| Download: 1161
45	Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy 9/5/2014 2:19:00 PM \| Browse: 1092 \| Download: 1143
46	Challenges in managing hepatitis C virus infection in cancer patients 9/1/2014 2:51:00 PM \| Browse: 1059 \| Download: 848
47	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection 9/1/2014 2:51:00 PM \| Browse: 1222 \| Download: 1229
48	Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children 8/28/2014 5:50:00 PM \| Browse: 1545 \| Download: 1224
49	Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C 8/26/2014 3:10:00 PM \| Browse: 1248 \| Download: 1490
50	Emerging therapeutic options for the management of hepatitis C infection 8/26/2014 2:46:00 PM \| Browse: 1122 \| Download: 1029